Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Masaki Yagi, Ph.D.

Concepts (96)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Masaki Yagi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Masaki Yagi has written about over time.
Embryonic Stem Cells, 4 publications between 2014 and 2017, average publication date March 2016. Pluripotent Stem Cells, 3 publications between 2017 and 2019, average publication date January 2018. Genomic Imprinting, 2 publications between 2017 and 2019, average publication date June 2018. Epigenesis, Genetic, 6 publications between 2015 and 2024, average publication date August 2019. Induced Pluripotent Stem Cells, 3 publications between 2015 and 2024, average publication date October 2019. Cell Differentiation, 10 publications between 2014 and 2024, average publication date December 2019. Transcription Initiation Site, 1 publications between 2020 and 2020, average publication date June 2020. DNA Methylation, 4 publications between 2017 and 2024, average publication date July 2020. Cell Lineage, 4 publications between 2017 and 2024, average publication date April 2021. Muscle Development, 1 publications between 2021 and 2021, average publication date August 2021. Myoblasts, 1 publications between 2021 and 2021, average publication date August 2021. MyoD Protein, 1 publications between 2021 and 2021, average publication date August 2021. Embryonic Development, 2 publications between 2019 and 2024, average publication date March 2022.

To see the data from this visualization as text, click here.
Yagi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (96)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.